Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

140.38 -1.13 (-0.80%)

Streaming Delayed Price Updated: 1:07 PM EDT, May 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

37 38 Next >

Illumina Plummets On Light Earnings Guidance Despite Quarterly Beat ↗

November 03, 2022

Illumina posted a wide miss for its full-year adjusted earnings outlook, leading shares to tumble after hours.

Via Investor's Business Daily

$1000 Invested In Illumina 20 Years Ago Would Be Worth This Much Today ↗

November 01, 2022

Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 18.98% on an annualized basis producing an average annual return of 26.53%. Currently, Illumina has a market capitalization...

Via Benzinga

Ranking 7 Top Tech Stocks to Buy From Biggest to Smallest ↗

October 28, 2022

Although "Big Tech" is currently struggling, but there are still many good top tech stocks to buy at this point.

Via InvestorPlace

Wall Street Is Still Bullish on This Punished Growth Stock -- Is It a Buy? ↗

October 27, 2022

Bionano's stock price movements have little to do with its successes.

Via The Motley Fool

Illumina Gains But Lags Market: What You Should Know ↗

October 24, 2022

In the latest trading session, Illumina (ILMN) closed at $220.57, marking a +0.25% move from the previous day. This move lagged the S&P 500's daily gain of 1.19%. Meanwhile, the Dow gained 1.34%, and...

Via Talk Markets

This Growth Stock Rose Last Week. Is It Still a Buy? ↗

October 18, 2022

Illumina is the dominant player in gene sequencing.

Via The Motley Fool

What 12 Analyst Ratings Have To Say About Illumina ↗

September 30, 2022

Analysts have provided the following ratings for Illumina (NASDAQ:ILMN) within the last quarter:

Via Benzinga

Illumina Stock Pops After European Regulators Block $8 Billion Deal ↗

September 06, 2022

The company has already acquired Grail, but may soon have to divest it.

Via Investor's Business Daily

Universal Sequencing Technology Corporation Announces High-Throughput Solution For NGS Library Preparation

October 24, 2022

UST releases high-throughput solution enabling second-generation short-read sequencers to produce long-range results in greater capacity.CARLSBAD, Calif. - Oct. 24, 2022 - PRLog -- Universal Sequencing...

Via PRLog

Topics Intellectual Property

Companion Diagnostics Industry to Witness Emergence of Players Including Abbott Laboratories, - bioMerieux, Illumina, Agilent Technologies, and Thermo Fisher Scientific –

October 18, 2022

This press release was orginally distributed by SBWire

Via ReleaseWire

Companion Diagnostics Industry to Witness Emergence of Players Including Abbott Laboratories, - bioMerieux, Illumina, Agilent Technologies, and Thermo Fisher Scientific –

October 18, 2022

London, UK -- (SBWIRE) -- 10/18/2022 -- The latest publication titled Companion Diagnostics – Thematic Research has been added to GlobalData Plc report store. Companion diagnostics (CDx) are molecular...

Via SBWire

Illumina Inks AI Pact With AstraZeneca To Accelerate Drug Target Discovery ↗

October 11, 2022

Via Benzinga

Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely ↗

October 11, 2022

One analyst doubts any deal could come to fruition. If it did, it would make sense.

Via Investor's Business Daily

Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years ↗

October 06, 2022

Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 19.07% on an annualized basis producing an average annual return of 26.54%. Currently, Illumina has a market capitalization...

Via Benzinga

Global Cervical Cancer Treatment Market Size Expected to Reach $11 Billion By 2027

October 06, 2022

Palm Beach, FL – October 6, 2022 – FinancialNewsMedia.com News Commentary – The global Cervical Cancer Treatment market has been expanding for several years and is projected to continue at a growing...

Via FinancialNewsMedia

Twitter, Ford And Other Big Gainers From Tuesday ↗

October 05, 2022

U.S. stocks closed sharply higher with the Dow Jones jumping more than 800 points on Tuesday. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Looking At Illumina's Recent Whale Trades ↗

October 04, 2022

A whale with a lot of money to spend has taken a noticeably bearish stance on Illumina. Looking at options history for Illumina (NASDAQ:ILMN) we detected 26 strange trades.

Via Benzinga

Why This Illumina Analyst Is Bullish About NovaSeq X+ ↗

October 04, 2022

Illumina, Inc.’s (NASDAQ: ILMN) NovaSeq X Plus is likely to become “the ultimate genome machine,” lending upside in 2024 and beyond, according to SVB Securities.

Via Benzinga

Is Illumina Still the Gamechanger in Genomics Sequencing?

October 04, 2022

Genome sequencing solutions company Illumina (NASDAQ: ILMN) stock has fallen under its pandemic lows. A surprise earnings miss, and lowered guidance has caused

Via MarketBeat

Topics Earnings Economy Lawsuit

CD Genomics RNA-Solutions Platform Now Provides Whole Transcriptome Sequencing Service

September 30, 2022

Via Get News

12 Analysts Have This to Say About Illumina ↗

September 30, 2022

Over the past 3 months, 12 analysts have published their opinion on Illumina (NASDAQ:ILMN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

3 Biotech Stocks to Sell in October ↗

September 29, 2022

These biotech stocks to sell are at a cross roads with their businesses with few growth catalysts ahead amid this turbulent market.

Via InvestorPlace

What Are Whales Doing With Illumina ↗

September 29, 2022

Someone with a lot of money to spend has taken a bullish stance on Illumina (NASDAQ:ILMN). And retail traders should know. We noticed this today when the big position showed up on publicly available...

Via Benzinga

Netflix, Biogen And Other Big Gainers From Wednesday ↗

September 29, 2022

U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022 ↗

September 28, 2022

Upgrades

Via Benzinga

7 Nasdaq Stocks to Buy on the Dip or You’ll Be Kicking Yourself Later ↗

September 21, 2022

Investors should consider buying these Nasdaq stocks on the dip while they still can before the market reverses higher.

Via InvestorPlace

US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing ↗

September 14, 2022

Via Benzinga

Biden Administration Pushes 'Cancer Moonshot' Initiative: Report ↗

September 13, 2022

President Joe Biden channeled John F. Kennedy on the 60th anniversary of the former President's moonshot speech, highlighting the Biden administration's efforts to "end cancer as we know it." The...

Via Benzinga

CNBC's Final Trades: Volkswagen, Illumina, Goldman Sachs And This Mobility Play ↗

September 13, 2022

On CNBC’s “Halftime Report Final Trades,” Stephen Weiss of Short Hills Capital Partners said that Volkswagen AG (OTC: VWAPY) is the “most compelling stock there is.&r

Via Benzinga

Top Financial Stories Thursday, September 6: Focus on iPhone 14 Event, OPEC+ Plans Mild Production Cut, Netflix Says No To Crypto Ads And More... ↗

September 06, 2022

Reuters EQT Corp Close To Buying THQ Appalachia

Via Benzinga

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

37 38 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.